Switching to Baricitinib From Adalimumab Provides Disease Control for Rheumatoid Arthritis - Rheumatology Advisor

Switching to Baricitinib From Adalimumab Provides Disease Control for Rheumatoid Arthritis  Rheumatology Advisor

For patients with rheumatoid arthritis (RA) who did not respond to adalimumab, switching to baricitinib provided disease control without increasing adverse ...